Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
14.10
-0.09 (-0.63%)
May 20, 2026, 11:44 AM CST

Walvax Biotechnology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
22,69517,44919,32037,60164,27489,423
Market Cap Growth
31.51%-9.69%-48.62%-41.50%-28.12%50.25%
Enterprise Value
23,49317,30018,56336,11762,95988,584
Last Close Price
14.1910.8812.0423.4140.0055.91
PE Ratio
79.9798.17135.9089.6688.21209.06
Forward PE
75.6883.3483.3483.3483.3483.34
PS Ratio
9.467.226.859.1412.6425.82
PB Ratio
2.901.831.683.305.858.94
P/TBV Ratio
3.462.252.314.578.1511.16
P/FCF Ratio
230.70-39.71199.74582.65-
P/OCF Ratio
35.8935.5418.6433.1653.50126.79
EV/Sales Ratio
9.797.156.588.7812.3825.58
EV/EBITDA Ratio
36.9035.6347.8932.2244.2795.49
EV/EBIT Ratio
97.82165.82773.0443.4653.63111.82
EV/FCF Ratio
238.81-38.16191.86570.72-
Debt / Equity Ratio
0.170.040.040.070.040.03
Debt / EBITDA Ratio
2.140.781.190.700.320.34
Debt / FCF Ratio
13.86-1.014.284.19-
Net Debt / Equity Ratio
0.05-0.13-0.28-0.31-0.31-0.31
Net Debt / EBITDA Ratio
0.63-2.63-8.44-3.17-2.40-3.37
Net Debt / FCF Ratio
3.9968.53-6.72-18.90-30.927.85
Asset Turnover
0.190.180.190.270.350.30
Inventory Turnover
1.010.950.830.740.720.60
Quick Ratio
1.672.012.632.372.242.07
Current Ratio
2.162.352.982.732.552.37
Return on Equity (ROE)
2.69%1.19%1.52%4.57%8.94%6.74%
Return on Assets (ROA)
1.18%0.49%0.10%3.36%5.06%4.25%
Return on Invested Capital (ROIC)
2.44%0.95%0.28%9.20%14.24%10.50%
Return on Capital Employed (ROCE)
2.60%1.00%0.20%6.70%9.90%7.60%
Earnings Yield
1.26%1.02%0.74%1.11%1.13%0.48%
FCF Yield
0.43%-0.11%2.52%0.50%0.17%-0.45%
Dividend Yield
0.29%1.42%0.08%0.04%0.03%0.05%
Payout Ratio
293.96%444.39%28.80%4.76%6.88%19.48%
Buyback Yield / Dilution
-1.49%-0.05%0.06%0.21%-1.93%-0.90%
Total Shareholder Return
-1.20%1.38%0.15%0.26%-1.91%-0.85%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.